MIF inhibition decreases tumor growth in murine ESCC models, concordant with patient studies correlating MIF serum and tumor enrichment with tumor dedifferentiation, vascular invasion, lymph node metastases, and worse survival [87,160,161]. The gene discussed is MIF; the disease is neoplasm.